Drug Use Survey (DUS) of Triple Therapy (Methycobal (MBL)+ Myonal (MYO)+ Non-steroidal Anti-inflammatory Drags (NSAID)) on the Symptom Relief of Lumbar DDD in China

Lumbar Disc Degenerative Disease Clinical Trial

Official title: A Retrospective Drug Use Survey (DUS) of Triple Therapy (Methycobal (MBL)+ Myonal (MYO)+ Non-steroidal Anti-inflammatory Drags (NSAID)) on the Symptom Relief of Lumbar Disc Degenerative Disease in China

Status Completed

Clinical Trial Summary

The purpose of this study is to observe the overall satisfaction of patients with degenerative disc disease after receiving triple therapy.

Clinical Trial Description

DDD (lumbar disc degenerative disease ) patients who have been prescribed triple therapy (MBL+ MYO+ NSAIDs) over 2 weeks of triple therapy were enrolled in the study. They were asked to assess their overall satisfaction degree on triple therapy. ;

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Intervertebral Disc Degeneration
• Lumbar Disc Degenerative Disease

• NCT number: NCT01299077
• Study type: Observational
• Source: Eisai Inc.
• Status: Completed
• Phase: N/A
• Start date: June 2010
• Completion date: November 2010